QCM
ZBIO

Quantinno Capital Management’s Zenas BioPharma ZBIO Stock Holding History

Quantinno Capital Management’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
8,581
-12,545
-59% -$249K ﹤0.01% 3320
2026
Q1 		$413K Buy
+21,126
New +$474K ﹤0.01% 2844

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Quantinno Capital Management's ZBIO Position: Q2 2026 in Review

Quantinno Capital Management reduced its Zenas BioPharma (ZBIO) stake by 59% in Q2 2026, selling an estimated $249K and leaving 8,581 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #3320.

Quantinno Capital Management first reported a position in ZBIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $413K in Q1 2026. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Quantinno Capital Management held 8,581 shares of Zenas BioPharma worth $218K as of Q2 2026.
  • Quantinno Capital Management sold 12,545 Zenas BioPharma shares in Q2 2026, an estimated $249K.
  • Zenas BioPharma made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3320 holding.
  • Quantinno Capital Management first reported a position in Zenas BioPharma in Q1 2026 and has held it in 2 quarters since.
  • Quantinno Capital Management's Zenas BioPharma position peaked at $413K in Q1 2026.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.